Who Qualifies for Weight Loss Injections in Malta? The Honest Criteria

Last reviewed by the Carisma Medical Team — 2026

Grace has been awake since 5 a.m. Not because of anxiety — though that is part of it — but because her body simply will not let her sleep through anymore. At 52, she is a department manager, a mother of two grown children, and the kind of woman who has always handled things. For eighteen months she has been managing something she cannot quite get on top of: her weight. Not from lack of effort. She has counted calories, cut carbs, rejoined the gym twice. But since perimenopause, the rules she always followed stopped working. So last Tuesday, sitting at her kitchen table with her coffee going cold, she typed something she had never typed before: who qualifies for weight loss injections Malta.

She found a list of numbers. BMI thresholds, comorbidity criteria, clinical exclusions. She closed the tab.

She did not want a checklist. She wanted someone to explain it properly.

This article is for Grace — and for every woman in Malta who has done the research at an inconvenient hour and still come away without a clear answer. Understanding who qualifies for weight loss injections in Malta is more nuanced than a single number on a scale, and knowing the honest criteria is the first step toward a decision that actually fits your life.

Key Takeaways - GLP-1 injections require a BMI of 30+, or 27+ with a qualifying health condition - A medically supervised assessment looks at far more than just your BMI number - Type 2 diabetes, high blood pressure, and sleep apnoea can all support eligibility - Certain contraindications — like medullary thyroid cancer history — are hard exclusions - A free consultation gives you a clear, personalised answer from a qualified clinician

What Are Weight Loss Injections?

GLP-1 medications explained simply

Weight loss injections — most commonly GLP-1 receptor agonists such as semaglutide (brand name Wegovy or Ozempic) and tirzepatide (brand name Mounjaro) — work by mimicking a hormone your body already produces. That hormone is called glucagon-like peptide-1, and it is released naturally after you eat. Its job is to tell your brain that you are full, slow the rate at which food moves through your stomach, and help your pancreas regulate blood sugar.

In people who struggle with persistent weight gain, that fullness signal often arrives too late or does not last long enough. GLP-1 medications effectively amplify and extend that signal, which reduces appetite suppression, lowers overall caloric intake, and — over weeks and months of consistent use — leads to meaningful, sustained weight loss. For individuals with insulin resistance, this hormonal support can be particularly significant in restoring metabolic balance.

Tirzepatide (Mounjaro) goes a step further. It activates not one but two hormonal pathways — GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) — and head-to-head trial data published in the New England Journal of Medicine (SURMOUNT-5, 2024) showed tirzepatide produced approximately 47% greater weight loss than semaglutide in adults with obesity. In the SURMOUNT-1 trial, participants on the highest dose achieved a mean body weight reduction of 20.9% over 72 weeks.

These are not cosmetic supplements. They are prescription medications that work at the level of your hormones and your brain.

Why they require a prescription in Malta

In Malta, as across the European Union, GLP-1 receptor agonists are classified as prescription-only medicines. The European Medicines Agency (EMA) granted approval for tirzepatide (Mounjaro) for chronic weight management in November 2023, based on a specific set of clinical criteria. This means a qualified healthcare provider — not a pharmacist, not a wellness coach, not an online quiz — must assess your individual health picture before these medications can be prescribed. That clinical gate is not a barrier. It is a safeguard that protects you. In a clinically supervised setting, that assessment is also the foundation of a programme designed around you specifically.

The BMI Threshold: What the Guidelines Say

BMI 30+ and BMI 27+ with health conditions

The EMA-approved eligibility criteria for GLP-1 receptor agonists for weight management are clear on paper:

BMI of 30 kg/m² or above (classified as obesity) — eligible regardless of other health conditions • BMI of 27 kg/m² or above (classified as overweight) — eligible when at least one weight-related health condition is also present, such as type 2 diabetes, high blood pressure, dyslipidaemia (elevated blood fats), obstructive sleep apnoea, or cardiovascular disease

So if you are calculating your BMI right now and it is 28 with high blood pressure, you are within the clinical criteria. If it is 31 with no other conditions, you are within the criteria. These thresholds exist because clinical trial data — including the STEP programme for semaglutide and the SURMOUNT programme for tirzepatide — was gathered specifically within these populations.

Results may vary for each individual, and clinical trial numbers represent averages across thousands of participants. In the STEP-1 trial (Wilding et al., NEJM 2021), 86.4% of participants on semaglutide achieved at least 5% body weight reduction, and 69.1% achieved at least 10%. In medically supervised programmes, those numbers represent real people — people like Grace — not a theoretical ideal.

Why BMI alone does not tell the whole story

BMI is a starting point, not a verdict. A doctor working in a medically supervised programme will consider it alongside waist circumference, body composition, metabolic rate, cardiovascular risk, and the specific way your weight affects your daily life and health. A woman with a BMI of 26.5 who has been diagnosed with pre-diabetes, has a family history of cardiovascular disease, and experiences joint pain that limits her mobility may have a compelling clinical case that warrants a thorough discussion. A woman with a BMI of 31 who is otherwise metabolically healthy will have a different profile entirely.

The number matters. But it is the beginning of the conversation, not the end of it.

Health Conditions That May Make You Eligible in Malta

Type 2 diabetes and pre-diabetes

Type 2 diabetes is one of the most clearly established comorbidities that supports eligibility at a BMI of 27 or above. GLP-1 medications were originally developed as diabetes treatments precisely because they stimulate glucose-dependent insulin secretion from pancreatic beta cells while suppressing glucagon — meaning they help regulate blood sugar directly, not just as a side effect of weight loss. For women with pre-diabetes, the clinical case is also strong: weight loss of 5-10% has been shown in multiple studies to delay or prevent progression to type 2 diabetes. In the STEP-2 trial (Davies et al., Lancet 2021), participants with type 2 diabetes on semaglutide achieved a mean 9.6% body weight reduction. Results may vary for each individual, but the metabolic benefits extend well beyond the number on the scale.

High blood pressure, sleep apnoea, and joint problems

Three other conditions that commonly appear alongside excess weight — and that are explicitly listed in the EMA's approved indication — are hypertension (high blood pressure), obstructive sleep apnoea, and cardiovascular disease.

If you wake up tired no matter how long you sleep. If your partner has mentioned your breathing at night. If your blood pressure reading has crept up to a level that your GP is monitoring. If your knees or hips ache in ways that were not there five years ago. Any of these could be relevant to your eligibility assessment in a medically supervised programme. They are not embarrassing disclosures — they are clinical data that helps your doctor prescribe in a way that is right for your body.

Who Should Not Take GLP-1 Injections

Medical contraindications

Clear contraindications exist and your doctor will screen for them at your initial assessment. They include:

A personal or family history of medullary thyroid carcinoma (a specific type of thyroid cancer) • A personal or family history of Multiple Endocrine Neoplasia syndrome type 2 (MEN2) • A history of severe gastrointestinal disease such as gastroparesis • Known hypersensitivity to the active ingredient (tirzepatide or semaglutide) • A history of pancreatitis, where causality with GLP-1 use has not been definitively established but caution applies

These are not listed here to alarm you. The vast majority of people who come to us asking about these medications do not have these conditions. They are listed here because you deserve honest, complete information — and because a thorough medical assessment is precisely how these risks are identified and managed before anything is prescribed.

Pregnancy, thyroid history, and other key exclusions

GLP-1 receptor agonists are not prescribed during pregnancy or while breastfeeding, as safety data in these populations is not established. Women who are planning a pregnancy are typically advised to discontinue treatment in advance of conception.

Thyroid history — specifically medullary thyroid carcinoma — is a hard exclusion, though it is worth noting that this refers to a specific and relatively rare subtype of thyroid cancer. General hypothyroidism or a non-cancerous thyroid condition does not automatically exclude you; this is a question to raise directly in your consultation where your full thyroid history can be reviewed.

What the Doctor Checks at Your Assessment

Questions you will be asked

At a medically supervised assessment, your doctor is building a complete picture of your health — not administering a pass/fail test. You will be asked about your weight history and any previous attempts at weight management, your current medications (some medications affect eligibility or require dose adjustment), your family medical history, any history of eating disorders, and your expectations and goals.

You will also be asked about lifestyle: your diet, activity level, sleep quality, and stress. Not to judge your current choices, but because these form the baseline against which any programme — whether medication-based or not — is calibrated.

Blood tests and vitals that inform the decision

Your assessment will typically include blood pressure, weight and height measurement, and a discussion of relevant blood work. Depending on your history, your doctor may request a blood panel that includes fasting glucose or HbA1c (a three-month blood sugar average), lipid profile, thyroid function, liver and kidney markers, and potentially full blood count. These results are not hurdles to clear. They are the information that allows a medically supervised team to prescribe with precision and monitor your progress safely.

This is what separates a medically supervised programme from an online prescription service with a five-question form.

What If You Are on the Borderline?

Alternative pathways if injections are not prescribed

Perhaps your BMI sits at 26 without a qualifying comorbidity. Perhaps your thyroid history requires further investigation before a decision can be made. Perhaps a blood result suggests that a different approach — or a combination of approaches — would serve you better right now.

This does not mean you have been turned away. It means your doctor is doing their job properly.

At Carisma Slimming, our medically supervised weight loss programme includes a range of evidence-based approaches beyond GLP-1 medication alone. For some clients, a structured dietary and lifestyle programme with ongoing clinical monitoring delivers significant results. For others, the combination of dietary support, body composition treatment, and metabolic coaching creates the foundation for long-term change. You can explore the full range of what our team offers through our medically supervised weight loss programme.

The consultation itself is not a prerequisite for being prescribed something. It is the means by which the right pathway for you — whether that is medication, structured support, or a combination — is identified by someone qualified to make that assessment. Results may vary for each individual, and the combination approach we build for your profile is what makes the difference.

How a full consultation gives you clarity

There is something that happens when you sit across from a clinician who is not in a rush, who has read your forms, and who asks the question you did not expect them to ask. The uncertainty Grace felt at 5 a.m. — not quite sure where she fell, not quite sure if she would be taken seriously — dissolves into something that feels more like direction. Women who go through this process often describe sleeping better, moving with less joint pain, and feeling like themselves again — not just lighter on the scale, but lighter in themselves.

A consultation is not a commitment to a specific treatment. It is clarity. It is someone trained in this area looking at your actual health picture and telling you, honestly, what they see and what they recommend. That is a different experience from a forum, a friend's advice, or a website that ranks you by a single number.

Book a free consultation at Carisma Slimming and get the honest answer your situation deserves.

FAQs About Weight Loss Injections in Malta

What BMI do you need for weight loss injections in Malta?

The EMA-approved eligibility criteria require a BMI of 30 kg/m² or above, or a BMI of 27 kg/m² or above with at least one weight-related health condition such as type 2 diabetes, high blood pressure, obstructive sleep apnoea, dyslipidaemia, or cardiovascular disease. These thresholds apply to medications such as tirzepatide (Mounjaro) and semaglutide. BMI is an important clinical indicator, but it is assessed alongside your full health picture. A doctor in a medically supervised setting will consider multiple factors, not BMI alone, before making a prescribing decision. Results may vary for each individual.

Can I get weight loss injections if I have thyroid problems?

It depends on your specific thyroid history. General hypothyroidism — an underactive thyroid — is not a contraindication to GLP-1 receptor agonists. However, a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) is a hard contraindication, and these medications are not prescribed in those cases. If you have a thyroid history of any kind, your doctor will review the specific details at your assessment. Do not self-exclude based on the word "thyroid" alone — bring your history to the consultation and let a clinician advise you properly.

Do I need to have tried dieting first before being eligible?

No specific requirement to have completed a prior structured diet programme exists within the EMA approved indications for these medications. Prescribing guidance states that GLP-1 receptor agonists should be used as an adjunct to a reduced-calorie diet and increased physical activity — meaning they work alongside lifestyle changes rather than replacing them. However, your doctor may ask about your history of previous weight management attempts as part of building a complete clinical picture. A history of multiple diet attempts that have not produced lasting results is extremely common among our clients, and is never used as a reason to discount or dismiss you.

Are weight loss injections safe if I have high blood pressure?

High blood pressure (hypertension) is actually one of the qualifying comorbidities that may support your eligibility for GLP-1 medication at a BMI of 27 or above. In clinical trials, weight loss achieved through GLP-1 receptor agonists has been associated with reductions in blood pressure as a secondary benefit. If you are currently on antihypertensive medication, your doctor will review your regimen carefully — because as your blood pressure improves with weight loss, your medication dose may need adjustment. This is precisely why medically supervised programmes monitor blood pressure and vital signs throughout treatment, not just at the start.

What happens at a weight loss injection consultation in Malta?

Your initial consultation at Carisma Slimming is a comprehensive medical assessment, not a sales conversation. Your clinician will review your health and weight history, current medications, any relevant blood work, and your goals and expectations. You will have the opportunity to ask every question you have been storing up. Based on that assessment, your doctor will explain which pathway — medication-based, lifestyle-based, or a combination — they recommend for you, and why. You leave with a clear picture and a clear plan, not a prescription handed over after a five-minute form. Book your free slimming consultation at Carisma to take that first step.

Can I be refused weight loss injections even if I meet the BMI criteria?

Yes, and it is worth understanding why. Meeting the BMI threshold is one part of the eligibility picture, not the entirety of it. A contraindication such as a personal or family history of medullary thyroid carcinoma, a current pregnancy, severe gastrointestinal disease, or a known hypersensitivity to the medication would mean injections are not appropriate for you — regardless of BMI. Additionally, a doctor may recommend a different pathway based on your full health profile, even if you technically meet the BMI criteria. This is not rejection. It is a prescriber taking their responsibility seriously. Being told that a different approach is better for your specific situation is a clinical service, not a closed door.

Next Step: Book a Consultation in Malta

You deserve support that is built around your actual health — not a number on a chart and not a forum post from someone whose body is not yours.

If you have read this article and found yourself in Grace's kitchen at 5 a.m., uncertain about whether you qualify and unsure whether you will be taken seriously — you are exactly the person our team is here for.

The consultation is not a commitment to any particular treatment. It is a conversation with a clinician who will look at your full picture — your health history, your blood work, your lifestyle, your goals — and give you an honest answer about what is right for you. Sometimes that is GLP-1 medication. Sometimes it is a structured programme from our GLP-1 Medical Weight Loss Programme. Often it is a combination. You will not know until you have spoken to someone qualified to tell you.

Picture yourself in eight weeks knowing, for the first time, that you are on the right path — not a path borrowed from someone else's success story, but one designed for your body, your health, and your life in Malta. Women who take this step tell us they sleep better, move with less pain, and feel genuinely like themselves again — wins that go far beyond the number on the scale.

Book your free slimming consultation at Carisma today. We are ready when you are.

With you every step, Katya

Image Credits

Hero Image URL: https://images.pexels.com/photos/7579831/pexels-photo-7579831.jpeg?auto=compress&cs=tinysrgb&dpr=2&h=650&w=940 • Photographer: cottonbro studio • Pexels Page: https://www.pexels.com/photo/a-doctor-talking-the-patient-7579831/ • Alt text: Doctor consulting a patient about who qualifies for weight loss injections Malta in a bright clinical setting • Caption: A thorough medical consultation is the first step to understanding whether weight loss injections are right for you. • Filename: blog-02-hero-doctor-patient-consultation.jpg • Query used: doctor patient consultation woman clinic

Inline Image URL: https://images.pexels.com/photos/15319047/pexels-photo-15319047.jpeg?auto=compress&cs=tinysrgb&dpr=2&h=650&w=940 • Photographer: beyzahzah • Alt text: Female nutritionist in a warm office setting holding broccoli surrounded by fresh fruits and vegetables • Query used: nutritionist wellness professional healthy food office